AEMD
Aethlon Medical, Inc.
Price Chart
Latest Quote
$2.40
Current Price| Previous Close | $2.53 |
| Open | $2.54 |
| Day High | $2.57 |
| Day Low | $2.35 |
| Volume | 33,094 |
Stock Information
| Shares Outstanding | 973K |
| Total Debt | $542K |
| Cash Equivalents | $5.85M |
| Net Income | $-11.26M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $2.34M |
| P/E Ratio | 0.01 |
| EPS (TTM) | $209.20 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 14/42| Debt to Equity | 0.13 |
| Debt to Earnings | -0.05 |
| Current Ratio | 3.13 |
| Quick Ratio | 2.90 |
| Avg Revenue Growth | -25.00% |
| Return on Equity | -261.31% |
| Avg FCF Growth | -6.11% |
| FCF Yield | -327.33% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $2.40 | 33,094 |
| 2026-01-30 | $2.50 | 16,300 |
| 2026-01-29 | $2.55 | 38,000 |
| 2026-01-28 | $2.65 | 36,600 |
| 2026-01-27 | $2.80 | 25,900 |
| 2026-01-26 | $3.01 | 127,100 |
| 2026-01-23 | $3.28 | 298,100 |
| 2026-01-22 | $3.05 | 63,300 |
| 2026-01-21 | $2.76 | 34,300 |
| 2026-01-20 | $2.70 | 29,900 |
| 2026-01-16 | $2.92 | 138,800 |
| 2026-01-15 | $2.71 | 43,500 |
| 2026-01-14 | $2.62 | 16,700 |
| 2026-01-13 | $2.57 | 131,100 |
| 2026-01-12 | $2.38 | 80,500 |
| 2026-01-09 | $2.38 | 97,400 |
| 2026-01-08 | $2.46 | 87,400 |
| 2026-01-07 | $2.73 | 46,500 |
| 2026-01-06 | $2.84 | 87,700 |
| 2026-01-05 | $2.75 | 26,900 |
About Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
đ° Latest News
Aethlon Medical announces pricing of $4.5M common stock, warrant offering
TipRanks âĸ 2025-09-05T13:25:35Z
BC-Most Active Stocks
Associated Press Finance âĸ 2025-08-21T14:30:16ZAethlon Medical Inc (AEMD) Q1 2026 Earnings Call Highlights: Strategic Focus on Australian ...
GuruFocus.com âĸ 2025-08-15T21:01:00Z
Income Statement (Annual)
Revenue
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Revenue | $0 | $0 | $574,245 | $294,165 |
| Operating Revenue | $0 | $0 | $574,245 | $294,165 |
Expenses
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Interest Expense | $10,109 | - | - | - |
| Total Expenses | $9,341,365 | $12,636,568 | $12,472,883 | $10,715,050 |
| Other Income Expense | $-4,334,738 | $-18,962 | $-142,121 | - |
| Other Non Operating Income Expenses | $-4,334,738 | $-18,962 | - | - |
| Net Non Operating Interest Income Expense | $288,013 | $447,356 | $10,973 | $0 |
| Interest Expense Non Operating | $10,109 | - | - | - |
| Operating Expense | $9,341,365 | $12,636,568 | $12,472,883 | $10,715,050 |
| General And Administrative Expense | $9,341,365 | $12,636,568 | $12,472,883 | $10,715,050 |
Income & Earnings
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,416,091 |
| Net Interest Income | $288,013 | $447,356 | $10,973 | $0 |
| Interest Income | $298,122 | $447,356 | $10,973 | $0 |
| Normalized Income | $-13,388,089 | $-12,208,174 | $-11,887,665 | $-10,416,091 |
| Net Income From Continuing And Discontinued Operation | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,416,091 |
| Total Operating Income As Reported | $-9,341,365 | $-12,636,568 | $-11,898,638 | $-10,420,885 |
| Net Income Common Stockholders | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,416,091 |
| Net Income | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,416,091 |
| Net Income Including Noncontrolling Interests | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,420,885 |
| Net Income Continuous Operations | $-13,388,090 | $-12,208,174 | $-12,029,786 | $-10,420,885 |
| Pretax Income | $-13,388,090 | $-12,208,174 | $-12,029,786 | $-10,420,885 |
| Interest Income Non Operating | $298,122 | $447,356 | $10,973 | $0 |
| Operating Income | $-9,341,365 | $-12,636,568 | $-11,898,638 | $-10,420,885 |
| Special Income Charges | - | $0 | $-142,121 | $0 |
Per Share Metrics
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Diluted EPS | $-8.58 | $-388.80 | $-47.20 | $-56.80 |
| Basic EPS | $-8.58 | $-388.80 | $-47.20 | $-56.80 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-13,038,422 | $-12,277,511 | $-11,515,625 | $-10,297,200 |
| Reconciled Depreciation | $339,559 | $359,057 | $240,892 | $123,685 |
| EBITDA (Bullshit earnings) | $-13,038,422 | $-12,277,511 | $-11,657,746 | $-10,297,200 |
| EBIT | $-13,377,981 | $-12,636,568 | $-11,898,638 | $-10,420,885 |
| Diluted Average Shares | $1,560,839 | $314,096 | $256,717 | $184,462 |
| Basic Average Shares | $1,560,839 | $314,096 | $256,717 | $184,462 |
| Diluted NI Availto Com Stockholders | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,416,091 |
| Selling General And Administration | $9,341,365 | $12,636,568 | $12,472,883 | $10,715,050 |
| Other Gand A | $5,467,273 | $7,430,117 | $8,029,331 | $6,089,248 |
| Salaries And Wages | $3,874,092 | $5,206,451 | $4,443,552 | $4,625,802 |
| Total Unusual Items | - | $0 | $-142,121 | $0 |
| Total Unusual Items Excluding Goodwill | - | $0 | $-142,121 | $0 |
| Gain On Sale Of Business | - | $0 | $-142,121 | $0 |
| Minority Interests | - | - | $0 | $4,794 |
Balance Sheet (Annual)
Assets
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Net Tangible Assets | $5,122,980 | $5,765,232 | $15,062,560 | $17,130,908 |
| Total Assets | $7,359,534 | $8,245,982 | $17,508,940 | $19,417,954 |
| Total Non Current Assets | $1,409,734 | $2,020,194 | $2,418,374 | $1,260,947 |
| Other Non Current Assets | $97,813 | $87,506 | $87,506 | $87,506 |
| Non Current Prepaid Assets | $33,305 | $33,305 | $33,305 | $33,305 |
| Goodwill And Other Intangible Assets | $550 | $1,100 | $1,650 | $2,200 |
| Other Intangible Assets | $550 | $1,100 | $1,650 | $2,200 |
| Current Assets | $5,949,800 | $6,225,788 | $15,090,566 | $18,157,007 |
| Other Current Assets | $448,539 | $505,983 | $557,623 | $956,623 |
| Current Deferred Assets | $0 | $277,827 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $5,501,261 | $5,441,978 | $14,532,943 | $17,072,419 |
| Cash And Cash Equivalents | $5,501,261 | $5,441,978 | $14,532,943 | $17,072,419 |
| Cash Equivalents | $5,157,887 | $4,736,469 | $13,910,973 | - |
| Cash Financial | $343,374 | $705,509 | $621,970 | $17,072,419 |
| Receivables | - | - | $0 | $127,965 |
| Accounts Receivable | - | - | $0 | $127,965 |
| Prepaid Assets | - | - | - | $956,623 |
Debt
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Debt | $649,751 | $940,316 | $1,209,028 | $729,410 |
| Long Term Debt And Capital Lease Obligation | $336,718 | $649,751 | $939,642 | $602,505 |
| Current Debt And Capital Lease Obligation | $313,033 | $290,565 | $269,386 | $126,905 |
Liabilities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $2,236,004 | $2,479,650 | $2,444,730 | $2,426,554 |
| Total Non Current Liabilities Net Minority Interest | $336,718 | $649,751 | $939,642 | $602,505 |
| Current Liabilities | $1,899,286 | $1,829,899 | $1,505,088 | $1,824,049 |
| Other Current Liabilities | $178,206 | - | - | - |
| Payables And Accrued Expenses | $1,408,047 | $1,539,334 | $1,235,702 | $1,352,597 |
| Payables | $534,524 | $777,862 | $432,889 | $499,962 |
| Accounts Payable | $534,524 | $777,862 | $432,889 | $499,962 |
| Current Deferred Liabilities | - | - | $0 | $344,547 |
Equity
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Common Stock Equity | $5,123,530 | $5,766,332 | $15,064,210 | $17,133,108 |
| Total Equity Gross Minority Interest | $5,123,530 | $5,766,332 | $15,064,210 | $16,991,400 |
| Stockholders Equity | $5,123,530 | $5,766,332 | $15,064,210 | $17,133,108 |
| Gains Losses Not Affecting Retained Earnings | $-17,133 | $-6,940 | $-6,141 | - |
| Other Equity Adjustments | $-17,133 | $-6,940 | $-6,141 | - |
| Retained Earnings | $-167,954,817 | $-154,566,728 | $-142,358,554 | $-130,329,181 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Treasury Shares Number | $574,500 | $0 | - | - |
| Ordinary Shares Number | $2,010,739 | $328,715 | $287,405 | $192,739 |
| Share Issued | $2,585,239 | $328,715 | $287,405 | $192,739 |
| Tangible Book Value | $5,122,980 | $5,765,232 | $15,062,560 | $17,130,908 |
| Invested Capital | $5,123,530 | $5,766,332 | $15,064,210 | $17,133,108 |
| Working Capital | $4,050,514 | $4,395,889 | $13,585,478 | $16,332,958 |
| Capital Lease Obligations | $649,751 | $940,316 | $1,209,028 | $729,410 |
| Total Capitalization | $5,123,530 | $5,766,332 | $15,064,210 | $17,133,108 |
| Additional Paid In Capital | $173,092,894 | $160,339,671 | $157,426,606 | $147,446,868 |
| Capital Stock | $2,586 | $329 | $2,299 | $15,421 |
| Common Stock | $2,586 | $329 | $2,299 | $15,421 |
| Long Term Capital Lease Obligation | $336,718 | $649,751 | $939,642 | $602,505 |
| Current Capital Lease Obligation | $313,033 | $290,565 | $269,386 | $126,905 |
| Current Accrued Expenses | $873,523 | $761,472 | $802,813 | $852,635 |
| Net PPE | $1,278,066 | $1,898,283 | $2,295,913 | $1,137,936 |
| Accumulated Depreciation | $-978,889 | $-990,550 | $-734,207 | $-493,864 |
| Gross PPE | $2,256,955 | $2,888,833 | $3,030,120 | $1,631,800 |
| Leases | $893,131 | $893,131 | $888,224 | $121,690 |
| Other Properties | $601,846 | $883,054 | $1,151,909 | - |
| Machinery Furniture Equipment | $761,978 | $1,112,648 | $989,987 | $813,412 |
| Properties | $0 | $0 | $0 | $0 |
| Minority Interest | - | - | $0 | $-141,708 |
| Current Deferred Revenue | - | - | $0 | $344,547 |
| Buildings And Improvements | - | - | $1,151,909 | $696,698 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Free Cash Flow | $-7,645,532 | $-10,380,677 | $-11,448,237 | $-10,116,350 |
Operating Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-7,645,532 | $-10,129,810 | $-10,505,128 | $-9,767,157 |
| Cash Flow From Continuing Operating Activities | $-7,645,532 | $-10,129,810 | $-10,505,128 | $-9,767,157 |
| Operating Gains Losses | - | $21,135 | $142,121 | - |
Investing Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Investing Cash Flow | $0 | $-250,867 | $-943,109 | $-349,193 |
| Cash Flow From Continuing Investing Activities | $0 | $-250,867 | $-943,109 | $-349,193 |
| Capital Expenditure | - | $-250,867 | $-943,109 | $-349,193 |
Financing Activities
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $3,539,907 | $1,322,383 | $8,927,211 | $17,456,092 |
| Financing Cash Flow | $7,727,384 | $1,287,605 | $8,914,718 | $17,367,974 |
| Cash Flow From Continuing Financing Activities | $7,727,384 | $1,287,605 | $8,914,718 | $17,367,974 |
| Net Other Financing Charges | $-183,783 | $-34,778 | $-12,493 | $-88,118 |
| Net Common Stock Issuance | $3,539,907 | $1,322,383 | $8,927,211 | $17,456,092 |
| Common Stock Issuance | $3,539,907 | $1,322,383 | $8,927,211 | $17,456,092 |
Other
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| End Cash Position | $5,599,074 | $5,529,484 | $14,620,449 | $17,159,925 |
| Beginning Cash Position | $5,529,484 | $14,620,449 | $17,159,925 | $9,908,301 |
| Effect Of Exchange Rate Changes | $-12,262 | $2,107 | $-5,957 | - |
| Changes In Cash | $81,852 | $-9,093,072 | $-2,533,519 | $7,251,624 |
| Proceeds From Stock Option Exercised | $4,371,260 | $0 | - | - |
| Net PPE Purchase And Sale | $0 | $-250,867 | $-943,109 | $-349,193 |
| Purchase Of PPE | $0 | $-250,867 | $-943,109 | $-349,193 |
| Change In Working Capital | $93,694 | $478,659 | $65,339 | $-251,110 |
| Change In Payables And Accrued Expense | $-20,229 | $488,891 | $-116,248 | $134,763 |
| Change In Payable | $-20,229 | $488,891 | $-116,248 | $134,763 |
| Change In Account Payable | $-53,360 | $156,678 | $-174,727 | $97,541 |
| Change In Prepaid Assets | $113,923 | $-10,232 | $398,169 | $-636,688 |
| Other Non Cash Items | $4,894,070 | $143 | $24,408 | $30,532 |
| Stock Based Compensation | $415,234 | $1,219,370 | $1,051,898 | $750,621 |
| Depreciation Amortization Depletion | $339,559 | $359,057 | $240,892 | $123,685 |
| Depreciation And Amortization | $339,559 | $359,057 | $240,892 | $123,685 |
| Amortization Cash Flow | $550 | $550 | $550 | - |
| Amortization Of Intangibles | $550 | $550 | $550 | - |
| Depreciation | $339,009 | $358,507 | $240,342 | - |
| Gain Loss On Sale Of PPE | $0 | $21,135 | $0 | - |
| Net Income From Continuing Operations | $-13,388,089 | $-12,208,174 | $-12,029,786 | $-10,420,885 |
| Change In Receivables | - | $0 | $127,965 | $21,117 |
| Changes In Account Receivables | - | $0 | $127,965 | $21,117 |
| Gain Loss On Sale Of Business | - | $0 | $142,121 | $0 |
| Change In Other Working Capital | - | - | $-344,547 | $229,698 |
| Repayment Of Debt | - | - | - | - |
| Interest Paid Supplemental Data | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Payments | - | - | - | - |